This award recognises a company that has successfully completed a significant, impactful or transformational private fundraise at Seed-Stage level.
It is open to private Europeanlife science companies only.
- Must be a fundraise by a private company - Must have raised the funds in the period between 1 September 2018 and 1 September 2019 - Must be a company with European headquarters
Judges will be paying particular attention to:
- Amount of funds raised - Process / speed / allocation fulfilment of securing of significant new funds - Level / reputation of investors attracted - Post-finance allocation / use of proceeds - Level of value creation / value realisation from raise
- Company research / technology focus and novelty / meeting unmet need
ARCTORIS, UNITED KINGDOM
CHRONOMICS, UNITED KINGDOM
CLOSED LOOP MEDICINE, UNITED KINGDOM
LATTICE MEDICAL, FRANCE
MOGRIFY, UNITED KINGDOM
LSX is an influential community of senior life science decision makers. We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.